US Real-world Patient Characteristics, Acute Medication Use, and Treatment Patterns for Patients Initiating Fremanezumab

被引：0

作者：

Seminerio, Michael ^{[1
]}

Thompson, Stephen F. ^{[1
]}

Cohen, Joshua M. ^{[1
]}

Tangirala, Krishna ^{[1
]}

Ariely, Rinat ^{[1
]}

Rubin, Alexander ^{[1
]}

Carr, Karen ^{[1
]}

Buse, Dawn C. ^{[2
]}

机构：

[1] Teva Branded Pharmaceut Prod R&D Inc, Montvale, NJ USA

[2] Albert Einstein Coll Med, Bronx, NY 10467 USA

来源：

NEUROLOGY | 2021年 / 96卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

4192

引用

页数：3

共 50 条

[1] Real-world patient characteristics, acute medication use, and treatment patterns for patients initiating fremanezumab treatment: A US retrospective claims analysis
Buse, D. C.
Seminerio, M. J.
Thompson, S. F.
Cohen, J. M.
Tangirala, K.
Ariely, R.
Rubin, A.
Carr, K.
HEADACHE, 2021, 61 : 72 - 73
[2] REAL-WORLD REDUCTIONS IN ACUTE MEDICATION USE FOR PATIENTS WITH MIGRAINE INITIATING FREMANEZUMAB: A 12-MONTH RETROSPECTIVE US CLAIMS ANALYSIS
Krasenbaum, L. J.
Driessen, M. T.
Seminerio, M. J.
DiEgidio, R.
Tian, M.
VALUE IN HEALTH, 2022, 25 (07) : S325 - S325
[3] Real-world reductions in migraine-related healthcare resource utilization and medication use with fremanezumab treatment in US migraine patients using concomitant acute gepants
Eugeni, P.
Rooney, M. E.
Saikali, N. P.
Niu, Z.
Driessen, M. T.
Krasenbaum, L. J.
Seminerio, M. J.
McVige, J. W.
HEADACHE, 2022, 62 : 158 - 158
[4] REAL-WORLD CHARACTERISTICS AND TREATMENT PATTERNS IN URTICARIA PATIENTS INITIATING OMALIZUMAB IN THE UNITED STATES
Wang, L.
Kavati, A.
Ke, X.
Wertz, D.
Huang, Q.
Willey, V.
Stephenson, J.
Ortiz, B.
Bernstein, B. Paknis J.
Beck, L.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S44 - S44
[5] Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United States
Ke, Xuehua
Kavati, Abhishek
Wertz, Debra
Huang, Qing
Wang, Liya
Willey, Vincent J.
Stephenson, Judith J.
Ortiz, Benjamin
Paknis, Brandee
Bernstein, Jonathan A.
Beck, Lisa A.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (07): : 598 - +
[6] A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United States
Lynda J. Krasenbaum
Vasantha L. Pedarla
Stephen F. Thompson
Krishna Tangirala
Joshua M. Cohen
Maurice T. Driessen
The Journal of Headache and Pain, 2022, 23
[7] A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United States
Krasenbaum, Lynda J.
Pedarla, Vasantha L.
Thompson, Stephen F.
Tangirala, Krishna
Cohen, Joshua M.
Driessen, Maurice T.
JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
[8] Real-world Reductions in Migraine and Headache Days for Patients With Chronic and Episodic Migraine Initiating Fremanezumab in the US
Cohen, Joshua M.
Thompson, Stephen
Patterson-Lomba, Oscar
Driessen, Maurice
Seminerio, Michael
Carr, Karen
Mu, Fan
NEUROLOGY, 2021, 96 (15)
[9] Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine
Maurice T. Driessen
Joshua M. Cohen
Stephen F. Thompson
Oscar Patterson-Lomba
Michael J. Seminerio
Karen Carr
Todor I. Totev
Rochelle Sun
Erica Yim
Fan Mu
Rajeev Ayyagari
The Journal of Headache and Pain, 2022, 23
[10] Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine
Driessen, Maurice T.
Cohen, Joshua M.
Thompson, Stephen F.
Patterson-Lomba, Oscar
Seminerio, Michael J.
Carr, Karen
Totev, Todor, I
Sun, Rochelle
Yim, Erica
Mu, Fan
Ayyagari, Rajeev
JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):

← 1 2 3 4 5 →